CT MPJE common mistakes
CT MPJE · Understand the traps and how to avoid them.
Studies only the federal CSA schedule rules and answers Connecticut controlled-substance questions by defaulting to them - for example assuming the federal five-refill/six-month rule is the operative limit, that a federal DEA registration alone authorizes a Connecticut prescriber, or that federal partial-fill rules settle the question.
Nearly every review resource leads with the federal CSA because it is uniform and easy to memorize, so the state overlay (stricter refill limits, Schedule II treatment, separate Connecticut controlled-substance registration for prescribers and for the pharmacy) gets skimmed as a footnote.
What to do instead
Build a two-column federal-vs-Connecticut table for each schedule covering: who needs which registration, refills permitted, partial fills, quantity limits, time limits on filling, and emergency oral orders with their follow-up written prescription window. Fill every Connecticut cell from the Connecticut statute/regulations and DCP Drug Control Division guidance, not from memory of another state.
Treats the Connecticut Prescription Monitoring Program as a voluntary tool a pharmacist opens only when a patient or prescription looks suspicious, and never considers the reporting side (dispenser submissions, zero reports, and correction of erroneous data).
In practice PMP use is discretionary and habitual; candidates carry that habit into the exam and forget that the statute creates affirmative query and submission duties with defined triggers and timeframes.
What to do instead
Write out, from the current statute and DCP guidance, the exact trigger for a mandatory query (which schedules, which supply thresholds, first fill versus periodic re-check), the dispenser reporting deadline and zero-report rule, and who may access data. Answer every PMP question by locating the trigger first, then the duty.
Equates 'licensed pharmacist' with 'authority to do everything, everywhere' - assuming one Connecticut license covers practice at any site, that an out-of-state pharmacy shipping into Connecticut needs nothing extra, and that technicians and supportive staff need no state credential.
Licensure content is studied as a list of titles rather than as a set of site-specific and role-specific registrations, so the distinctions between personal licensure, pharmacy licensure, nonresident pharmacy registration, and technician registration blur together.
What to do instead
Draw a one-page map: who is credentialed (pharmacist, technician, pharmacy, nonresident pharmacy, prescriber CS registration), by which agency, and what each credential authorizes. For any scenario question, ask 'who is performing the act, and from what site?' before choosing an answer.
Fills in prescription-content questions using a federal or home-state template - omitting Connecticut-required data elements, misapplying what a pharmacist may add or change on a prescription, and mishandling oral/emergency controlled-substance orders and their written follow-up.
Prescription elements look interchangeable across states, so candidates answer from pattern recognition instead of checking the Connecticut-required data set and the state's rules on pharmacist corrections and prescriber authentication.
What to do instead
Memorize the Connecticut prescription data set as a checklist and rehearse it against a sample controlled-substance prescription and a sample legend-drug prescription, noting which fields the pharmacist may complete, which must come from the prescriber, and the deadline for reducing an emergency oral controlled-substance order to writing.
Treats USP <795> and <797> as voluntary best practice, and answers compounding questions without distinguishing sterile from nonsterile requirements - using one beyond-use-date logic, one cleaning/verification log set, and one recordkeeping rule for both.
Compounding is learned on the job under one site's SOPs, so candidates answer from their own workflow rather than from the enforceable standard and the state's adoption of it.
What to do instead
Create two separate one-page summaries (nonsterile vs sterile) covering personnel training and competency documentation, facility and environmental monitoring, assigned beyond-use dates by category, release testing, and records. Then confirm which of these Connecticut incorporates by reference and what additional state requirements attach to sterile compounding.
Answers counseling and drug utilization review questions as if counseling is discretionary - no documented offer, no documented refusal, and no prospective DUR screen before the product leaves the pharmacy.
Candidates conflate what happens on a busy shift (counseling often skipped or informal) with the legal minimum, and they underestimate how often exam items hinge on documentation of the offer rather than the conversation itself.
What to do instead
Practice a fixed script: screen for therapeutic duplication, interactions, dose and duration issues before dispensing; offer counseling on every new prescription; document acceptance or refusal. Know who may counsel, when a pharmacist's counseling may be delegated, and what must be documented when the patient declines.
Applies a single retention period (typically the federal two-year floor) to every record in the pharmacy, and cannot say which records must be readily retrievable on site versus stored, or which records carry a longer Connecticut retention period.
Two years is the number candidates learn first for controlled-substance records, so it becomes the default answer for prescription files, compounding logs, counseling notes, and inventories alike.
What to do instead
Build a retention matrix: record type, federal minimum, Connecticut minimum, format permitted, and where it must be kept. Verify each Connecticut figure against the statute/regulations rather than extrapolating from the federal two-year floor, and note which records must be produced on immediate request during an inspection.
Assumes institutional and long-term care dispensing is governed entirely by federal Medicare/OBRA conditions of participation, and never checks whether the off-site, satellite, or automated dispensing unit itself needs Connecticut licensure or registration.
Hospital and LTC practice feels federally regulated, so state facility licensure, satellite registration, and pharmacist responsibility for unit-dose and automated systems get treated as operational rather than legal questions.
What to do instead
For each setting (hospital, satellite, LTC, assisted living, clinic), list the Connecticut license or registration the entity needs, the pharmacist-in-charge and consultant-pharmacist duties, drug regimen review frequency, and the rules for automated dispensing and emergency kits. Answer scenario questions by identifying the site's credential first.
Treats DSCSA as a wholesaler problem - does not verify trading-partner licensure, cannot describe the transaction information a pharmacy must receive and retain, and has no procedure for quarantine and investigation when product is suspect or illegitimate.
At the dispensing counter product arrives already pedigreed, so the pharmacy's own verification, recordkeeping, and suspect-product obligations never get exercised and therefore never get studied.
What to do instead
Learn the pharmacy's DSCSA role as a dispenser: verify and retain transaction information, confirm trading partners are appropriately licensed, and know the written steps for suspect and illegitimate product (quarantine, notify, investigate, retain records). Pair this with REMS - know that a REMS restriction can make a pharmacy ineligible to dispense even with a valid license, and that certification and documentation are separate from state licensure.
Answers confidentiality questions using HIPAA alone - releasing prescription and controlled-substance information without considering Connecticut's own confidentiality provisions or the stricter federal rules for substance-use-disorder records.
HIPAA is the only privacy framework most candidates have been trained on, so state prescription-confidentiality rules and the special protections for SUD treatment records are invisible on exam day.
What to do instead
Build a short hierarchy: HIPAA floor, stricter federal SUD-record rules, then Connecticut confidentiality provisions, and identify which applies to the request at hand (law enforcement subpoena, prescriber request, patient authorization, insurance audit). Note where Connecticut is stricter than HIPAA and where consent must be specific rather than general.